NEW YORK (GenomeWeb) – A team led by Johns Hopkins Kimmel Cancer Center researchers has developed a model that uses routine pathologic parameters to identify breast cancer patients for whom molecular-based recurrence testing with Oncotype DX is likely to provide added information.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.